Affiliation:
1. Academic Unit of Bone Metabolism, University of Sheffield, Sheffield S5 7AU, United Kingdom
Subject
Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference20 articles.
1. Prevention of bone loss in survivors of breast cancer: a randomized, double-blind, placebo-controlled clinical trial.;Greenspan;J Clin Endocrinol Metab,2007
2. Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study.;Delmas;J Clin Oncol,1997
3. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.;Saarto;J Clin Oncol,1997
4. Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer.;Powles;J Natl Cancer Inst,1998
5. Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients;Vehmanen;The effect of adjuvant clodronate treatment. Eur J Cancer,2001
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献